Hemostasis Today

November, 2026
November 2026
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Cajetan Reichardt: LAAO vs. OAC in AF – Balancing Nonprocedural Bleeding and Ischemic Stroke Risk
Nov 17, 2026, 23:45

Cajetan Reichardt: LAAO vs. OAC in AF – Balancing Nonprocedural Bleeding and Ischemic Stroke Risk

Cajetan Reichardt, Clinical Research Assistant at TUM University Hospital – German Heart Center, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Revista Española de Cardiología, adding:

“Thrilled to share my first scientific publication as a joint first author!

Our systematic review and meta-analysis, ‘Percutaneous Left Atrial Appendage Occlusion vs. Oral Anticoagulation in Patients with Atrial Fibrillation‘ has been recently published in Revista Española de Cardiología (IF 4.2)

7 studies, 7,353 participants

Study highlight: We reviewed randomized clinical trials comparing percutaneous LAAO with OACs (either a vitamin K antagonist or a direct oral anticoagulant) in patients with AF.

Key results: There were no significant differences between LAAO and OAC in terms of all-cause death, stroke or any bleeding.

LAAO reduced nonprocedural bleeding, but was associated with a numerically higher risk of ischemic stroke. There was a significant interaction between LAAO and the type of OAC regimen in terms of all-cause death.

I would like to express my sincere gratitude to my co-authors Maddalena Immobile Molaro and Fiorenzo Simonetti, mentors and colleagues for their hard work and collaboration!”

Title: Percutaneous left atrial appendage occlusion versus oral anticoagulation in patients with atrial fibrillation: a systematic review and meta-analysis

Authors: Maddalena Immobile Molaro, Cajetan Reichardt, Fiorenzo Simonetti, Doruntina Lahu, Gjin Ndrepepa, Tobias Lenz, Costanza Pellegrini, Moritz von Scheidt, Tobias Rheude, Felix Voll, Héctor Alfonso Álvarez Covarrubias, Teresa Trenkwalder, Hendrik B. Sager, Heribert Schunkert, Michael Joner, Adnan Kastrati, Salvatore Cassese, Erion Xhepa

Cajetan Reichardt

Stay updated on all scientific advances with Hemostasis Today.